MDMA approval for post-traumatic stress disorder could come in 2024

The Food and Drug Administration soon may approve recreational psychedelic drug MDMA -- alongside supportive therapy -- to treat post-traumatic stress disorder after two late-stage studies found it effective.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news